Last reviewed · How we verify
NCT03533543: NOAFCAMI-SH
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in ShangHai
trial testing CEM in Atrial Fibrillation in 2,399 participants. Completed in 13 September 2019.
1 June 2019
Quick facts
| Lead sponsor | Shanghai 10th People's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,399 |
| Start date | 20 May 2018 |
| Primary completion | 1 June 2019 |
| Estimated completion | 13 September 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- CEM
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Myocardial Infarction — all drugs for Myocardial Infarction →
Sponsor
Shanghai 10th People's Hospital
Who can join
18 and older, any sex, with Atrial Fibrillation or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To characterize and estimate the incidence rate of new-onset atrial fibrillation (NOAF) in patients with acute myocardial infarction (MI). To explore the prognostic influences of NOAF on MI patients' clinical outcomes. To further investigate the impact of NOAF associated characteristics on patients' clinical outcomes eithier during hospitalization or follow-up period.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabetes: insights from the NOAFCAMI-SH registry.
Luo J, Qin X, Zhang X, Zhang Y, et al · · 2024 · cited 37× · PMID 38254086 · DOI 10.1186/s12933-024-02129-x -
Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.
Luo J, Xu S, Li H, Li Z, et al · · 2020 · cited 34× · PMID 32578394 · DOI 10.1002/ehf2.12872 -
Prognostic impact of stress hyperglycemia ratio in acute myocardial infarction patients with and without diabetes mellitus.
Luo J, Xu S, Li H, Li Z, et al · · 2022 · cited 28× · PMID 35965248 · DOI 10.1016/j.numecd.2022.07.004 -
Association of stress hyperglycemia ratio with in-hospital new-onset atrial fibrillation and long-term outcomes in patients with acute myocardial infarction.
Luo J, Li Z, Qin X, Zhang X, et al · · 2024 · cited 23× · PMID 37712510 · DOI 10.1002/dmrr.3726 -
Prognostic Impact of the Symptom of New-Onset Atrial Fibrillation in Acute Myocardial Infarction: Insights From the NOAFCAMI-SH Registry.
Luo J, Liu B, Li H, Xu S, et al · · 2021 · cited 9× · PMID 34631808 · DOI 10.3389/fcvm.2021.677695 -
Prognostic impact of new-onset atrial fibrillation in myocardial infarction with and without improved ejection fraction.
Luo J, Qin X, Zhang X, Zhang Y, et al · · 2024 · cited 5× · PMID 38984376 · DOI 10.1002/ehf2.14956
Verify or expand the search:
- PubMed search for NCT03533543
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CEM
Trials testing the same drug.
- NCT04097366 — Breast Screening - Risk Adaptive Imaging for Density · NA · active not recruiting
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Shanghai 10th People's Hospital trials
Trials by the same sponsor.
- NCT07528040 — An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With C · not yet recruiting
- NCT07370441 — Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients · Phase 4 · not yet recruiting
- NCT07328100 — Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. · NA · not yet recruiting
- NCT06783296 — Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension · NA · not yet recruiting
- NCT07204496 — A Clinical Study on the Safety, Tolerance, and Preliminary Efficacy of γδ-T Cell Injection in the Treatment of Advanced · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03533543 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai 10th People's Hospital
- Last refreshed: 16 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03533543.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing